A detailed history of Lmr Partners LLP transactions in Astrazeneca PLC stock. As of the latest transaction made, Lmr Partners LLP holds 50,000 shares of AZN stock, worth $3.28 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
50,000
Previous 25,886 93.15%
Holding current value
$3.28 Million
Previous $2.02 Million 93.06%
% of portfolio
0.04%
Previous 0.02%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$76.67 - $87.62 $812,702 - $928,772
-10,600 Reduced 40.95%
15,286 $1.19 Million
Q2 2024

Aug 14, 2024

SELL
$66.81 - $80.83 $16.3 Million - $19.7 Million
-243,230 Reduced 90.38%
25,886 $2.02 Million
Q1 2024

May 15, 2024

SELL
$61.03 - $69.57 $512,652 - $584,388
-8,400 Reduced 3.03%
269,116 $18.2 Million
Q4 2023

Feb 14, 2024

SELL
$61.89 - $69.28 $7.71 Million - $8.63 Million
-124,600 Reduced 30.99%
277,516 $18.7 Million
Q3 2023

Nov 14, 2023

SELL
$64.85 - $71.7 $37.3 Million - $41.3 Million
-575,319 Reduced 58.86%
402,116 $27.2 Million
Q2 2023

Aug 14, 2023

BUY
$69.91 - $75.81 $25.3 Million - $27.5 Million
362,607 Added 58.98%
977,435 $70 Million
Q1 2023

May 15, 2023

BUY
$63.15 - $71.6 $38.8 Million - $44 Million
614,828 New
614,828 $42.7 Million
Q4 2021

Feb 14, 2022

SELL
$54.02 - $63.83 $14.6 Million - $17.3 Million
-271,173 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$55.56 - $60.79 $15.1 Million - $16.5 Million
271,173 New
271,173 $16.4 Million
Q1 2021

May 17, 2021

SELL
$47.16 - $54.44 $5.97 Million - $6.89 Million
-126,605 Closed
0 $0
Q4 2020

Feb 16, 2021

SELL
$48.52 - $58.02 $933,961 - $1.12 Million
-19,249 Reduced 13.2%
126,605 $6.33 Million
Q3 2020

Nov 16, 2020

BUY
$53.07 - $61.1 $5.62 Million - $6.47 Million
105,854 Added 264.64%
145,854 $7.99 Million
Q2 2020

Aug 14, 2020

BUY
$43.1 - $55.31 $1.72 Million - $2.21 Million
40,000 New
40,000 $2.12 Million

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $203B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Lmr Partners LLP Portfolio

Follow Lmr Partners LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lmr Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Lmr Partners LLP with notifications on news.